- Investor's Business Daily•7 days ago
Biotech stocks notched an eight-month high for a third straight day, with FDA actions and M&A sparking some gains.
- Motley Fool•7 days ago
Shares nearly doubled in response to the thumbs up from U.S. regulators on eteplirsen, its treatment for Duchenne muscular dystrophy. Should investors hop on board now?
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||11.73 x 400|
|Ask||11.76 x 200|
|Day's Range||11.57 - 12.24|
|52wk Range||5.27 - 35.76|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.28|
|Avg Vol (3m)||1,199,332|
|Dividend & Yield||N/A (N/A)|